TransCode Therapeutics, Inc. · NASDAQ:RNAZ

TransCode Therapeutics, Inc. shareholders

As of Sep 30, 2026, 12 institutions reported holding TransCode Therapeutics, Inc., 0.58% of its shares. Largest: Yorkville Advisors Global, LP, Citadel and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of TransCode Therapeutics, Inc.ChangeFiled
Yorkville Advisors Global, LP75,7860.44%+56,147Nov 12, 2026
Citadel10,2070.06%newNov 16, 2026
Vanguard9,5270.06%no changeNov 13, 2026
UBS2,6500.02%−238Nov 10, 2026
Tower Research Capital LLC (TRC)1,7460.01%+1,069Nov 16, 2026
Osaic Holdings, Inc.270<0.01%newNov 12, 2026
Robinhood Markets, Inc.102<0.01%first reportNov 18, 2026
Wells Fargo55<0.01%no changeNov 16, 2026
SBI Securities Co., Ltd.12<0.01%no changeOct 21, 2026
Fidelity11<0.01%−695Nov 10, 2026

TransCode Therapeutics, Inc. insider trades